General Information of Drug Inactive Ingredient (DIG) (ID: E00133)

DIG Name
Methyl methacrylate
Synonyms
METHYL METHACRYLATE; 80-62-6; Methylmethacrylate; Methacrylic acid methyl ester; methyl 2-methylprop-2-enoate; Methyl methylacrylate; Methyl 2-methylpropenoate; Pegalan; Methyl-methacrylat; 2-Propenoic acid, 2-methyl-, methyl ester; Diakon; Acryester M; Methyl 2-methyl-2-propenoate; Methacrylate de methyle; Methyl 2-methylacrylate; 2-Methyl-2-propenoic acid methyl ester; Methacrylsaeuremethyl ester; 2-(Methoxycarbonyl)-1-propene; Metakrylan metylu; Methylmethacrylaat; Metil metacrilato; Rcra waste number U162; Methyl alpha-methylacrylate; Methyl methacrylate monomer; TEB 3K; NCI-C50680; 2-Methylacrylic acid, methyl ester; Methacrylic acid, methyl ester; Eudragit; Acrylic acid, 2-methyl-, methyl ester; 2-Methyl-acrylic acid methyl ester; NSC 4769; Monocite methacrylate monomer; Methylester kyseliny methakrylove; CHEBI:34840; Polymethyl methacrylate; 2-methylacrylic acid methyl ester; UNII-196OC77688; Methyl .alpha.-methylacrylate; Cranioplast; Metaplex; Kallocryl A; Simplex P; MFCD00008587; Methyl methacrylate monomer, inhibited; Methyl methacrylate, 99%, stabilized; Methyl ester of 2-methyl-2-propenoic acid; 196OC77688; Methylmethacrylaat [Dutch]; Metakrylan metylu [Polish]; Methyl-methacrylat [German]; Metil metacrilato [Italian]; 9065-11-6; CCRIS 1364; HSDB 195; Methacrylate de methyle [French]; poly(methylmethacrylate); Methacrylsaeuremethyl ester [German]; EINECS 201-297-1; UN1247; RCRA waste no. U162; BRN 0605459; Plexiglass; Methylester kyseliny methakrylove [Czech]; Plexiglas; Methyl methacrylate homopolymer; AI3-24946; methoxymethacrolein; PMMA [Polymer]; DSSTox_CID_844; Epitope ID:131321; Methyl 2-methylacrylate #; Methyl methacrylate (MMA); EC 201-297-1; Methyl-.alpha.-methacrylate; SCHEMBL1849; DSSTox_RID_75823; UNII-Z47NNT4J11; CH2=C(CH3)COOCH3; DSSTox_GSID_20844; Methacrylic acid-methyl ester; 4-02-00-01519 (Beilstein Handbook Reference); NA 1247 (Salt/Mix); UN 1247 (Salt/Mix); BIDD:ER0634; CHEMBL49996; Methyl methacrylate, 99.5%; WLN: 1UY1&VO1; Z47NNT4J11; 2-Propenoic acid, 2-methyl-, methyl ester, homopolymer; DTXSID2020844; Methyl methacrylate, CP,98.0%; NSC4769; NSC-4769; ZINC1680392; C(C(=C)C)(=O)O[C]; Tox21_200367; ANW-37384; SBB060556; STL283952; AKOS000120216; MCULE-9286083206; CAS-80-62-6; NCGC00091089-01; NCGC00091089-02; NCGC00257921-01; DB-013559; M0087; ST51046719; 3855-EP2269995A1; 3855-EP2270101A1; 3855-EP2270113A1; 3855-EP2272822A1; 3855-EP2272935A1; 3855-EP2275418A1; 3855-EP2295406A1; 3855-EP2298744A2; 3855-EP2301924A1; 3855-EP2305219A1; 3855-EP2305683A1; 3855-EP2311839A1; 3855-EP2314589A1; 3855-EP2316837A1; C14527; C19504; Methyl methacrylate 1000 microg/mL in Methanol; Methyl methacrylate, SAJ first grade, >=99.0%; 2-Methyl-2-propenoic acid methyl ester homopolymer; A839957; Q382897; J-522614; F0001-2087; Z966691016; Methacrylic acid-methyl ester 100 microg/mL in Cyclohexane; Methyl Methacrylate (stabilized with 6-tert-Butyl-2,4-xylenol); Methyl Methacrylate, (stabilized with 6-tert-Butyl-2,4-xylenol); Methyl methacrylate, contains <=30 ppm MEHQ as inhibitor, 99%; Methyl methacrylate, European Pharmacopoeia (EP) Reference Standard; Methyl methacrylate (MMA), 99.5%(GC), contains 30ppm MEHQ as stabilizer; Methyl methacrylate (MMA), AR, 99.0%, contains 30ppm MEHQ as stabilizer; Methyl methacrylate monomer, inhibited [UN1247] [Flammable liquid]; PROPENOIC ACID,2-METHYL,METHYLESTER (METHACRYLATE METHYLESTER)
DIG Function
Film/membrane-forming agent
Formula
C5H8O2
Canonical SMILES
CC(=C)C(=O)OC
InChI
1S/C5H8O2/c1-4(2)5(6)7-3/h1H2,2-3H3
InChIKey
VVQNEPGJFQJSBK-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 100.12 Topological Polar Surface Area 26.3
XlogP 1.4 Complexity 94.3
Heavy Atom Count 7 Rotatable Bond Count 2
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2

Full List of Drug(s) Co-administrated with This DIG

3 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Flavoxate DMKV4NL Dysuria [MF50.7] Flavoxate 100 mg tablet F08264
Nifedipine DMSVOZT Angina pectoris [BA40] Nifedipine 30 mg tablet F15263
Tolterodine DMSHPW8 Overactive bladder [GC50.0] Tolterodine 2 mg capsule F05431
------------------